Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 5Breast 5CNS 3Thoracic 2Other solid neoplasm 2Head & Neck 2Genitourinary 2Tumor-Agnostic 1Other hematologic neoplasm 1

Conditions

Mesothelioma 2

Interventions

Carboplatin 1152Cisplatin 876Pemetrexed 834pembrolizumab 608Paclitaxel 598Docetaxel 535Gemcitabine 424Radiotherapy 377Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 295durvalumab 254Drug Therapy 233osimertinib 218atezolizumab 208Radiosurgery 190Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 124Magnetic Resonance Spectroscopy 121Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Magnesium Sulfate × Thoracic × Clear all
NCT05730816 2025-11-21

MAGIC-AKI

Brigham and Women's Hospital

Phase 2 Recruiting
130 enrolled
Other solid neoplasmThoracic

Mesothelioma

NCT04481672 2022-01-11

Intravenous Magnesium in Patients Receiving Cisplatin

Dana-Farber Cancer Institute

Phase 1 Completed
5 enrolled
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡